Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia

Full text
Author(s):
Show less -
de Jesus, Joyce de Cassia Rosa [1] ; Murari, Ariene Soares de Pinho [1] ; Radloff, Katrin [1] ; de Moraes, Ruan Carlos Macedo [1] ; Figueredo, Raquel Galvao [1] ; Pessoa, Ana Flavia Marcal [1] ; Rosa-Neto, Jose Cesar [2] ; Matos-Neto, Emidio Marques [1] ; Alcantara, Paulo S. M. [3] ; Tokeshi, Flavio [3] ; Maximiano, Linda Ferreira [3] ; Bin, Fang Chia [4] ; Formiga, Fernanda Bellotti [4] ; Otoch, Jose P. [1, 3] ; Seelaender, Marilia [1]
Total Authors: 15
Affiliation:
[1] Univ Sao Paulo, Fac Med, Dept Surg, Canc Metab Res Grp, Lab Invest Med LIM26, Sao Paulo - Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Immunometab Lab, Sao Paulo - Brazil
[3] Univ Sao Paulo, Dept Surg Clin, Univ Hosp, Sao Paulo - Brazil
[4] Santa Casa Sao Paulo, Dept Coloproctol, Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: FRONTIERS IN IMMUNOLOGY; v. 12, SEP 23 2021.
Web of Science Citations: 0
Abstract

Background Cachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors which drive the systemic inflammation, a hallmark of the syndrome. While inflammation is a defensive innate response, the control mechanisms have been reported to be disrupted in cachexia. On the other hand, little is known about the role of NLRP3 inflammasome in this scenario, a multiprotein complex involved in caspase-1 activation and the processing of the cytokines IL-1 beta and IL-18.</p> Aim based on the evidence from our previous study with a rodent model of cachexia, we examined the activation of the NLRP3 inflammasome pathway in two adipose tissue depots obtained from patients with colorectal cancer and compared with that another inflammatory pathway, NF-kappa B.</p> Results For CC we found opposite modulation in ScAT and PtAT for the gene expression of TLR4, Caspase-1 (cachectic group) and for NF-kappa B p50, NF-kappa B p65, IL-1 beta. CD36, expression was decreased in both depots while that of NLRP3 and IL-18 was higher in both tissues, as compared with controls and weight stable patients (WSC). Caspase-1 basal protein levels in the ScAT culture supernatant were higher in WSC and (weight stable patients) CC, when compared to controls. Basal ScAT explant culture medium IL-1 beta and IL-18 protein content in ScAT supernatant was decreased in the WSC and CC as compared to CTL explants.</p> Conclusions The results demonstrate heterogeneous responses in the activation of genes of the NLRP3 inflammasome pathway in the adipose tissue of patients with cancer cachexia, rendering this pathway a potential target for therapy aiming at decreasing chronic inflammation in cancer.</p> (AU)

FAPESP's process: 12/50079-0 - Systemic inflammation in cachectic cancer patients: mechanisms and therapeutical strategies, a translational medicine approach
Grantee:Marilia Cerqueira Leite Seelaender
Support Opportunities: Research Projects - Thematic Grants